Dosage and administration
apply liberally 15 minutes before sun exposure. reapply at least every 2 hours. use a water-resistant sunscreen if swimming or sweating. children under 6 months of age: Ask a doctor.
Belo Intensive Brightening
- Manufacturer
- Intelligent Skin Care Inc.
- Effective date
- 2022-11-29
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:45:50
Label at a glance#
ProductBelo Intensive Brightening
Active ingredientOXYBENZONE, TITANIUM DIOXIDE, OCTOCRYLENE, OCTINOXATE
Label structure9 sections
Label contents#
Full prescribing information#
Active Ingredients
Active Ingredients Purpose
Octyl methoxycinnamate 6% Sunscreen
Octocrylene .60%
Oxybenzone .50%
Titanium dioxide .41%
Purpose
Purpose
Sunscreen
Use
Use
helps prevent sunburn
Warnings
Skin Cancer/Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging.
For external use only
OTC - DO NOT USE SECTION
Do not use on damaged or broken skin
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
Stop use and ask a doctor if rash occurs.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If product is swallowed, get Poison Control Center right away.
Directions
- apply liberally 15 minutes before sun exposure.
- reapply at least every 2 hours.
- use a water-resistant sunscreen if swimming or sweating.
- children under 6 months of age: Ask a doctor.
Other Information
Other Information
protect the product in this container from excessive heat and direct sun
- high sun protection product
Inactive Ingredients
Inactive Ingredients
Questions or Comments?
Questions or Comments?
+63 2 7500 3825 or inquiries@iskincareinc.com
label
Products#
Every source-derived product name is available through these pages.
- Belo Intensive Brightening
- Octyl methoxycinnamate, Titanium dioxide, Octocrylene, Octinoxate
- CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE
- OXYBENZONE
- BUTYROSPERMUM PARKII (SHEA) BUTTER UNSAPONIFIABLES
- TITANIUM DIOXIDE
- OCTOCRYLENE
- LEVOMENOL
- OCTINOXATE
- CETOSTEARYL ALCOHOL
- DIMETHICONE
- BUTYLENE GLYCOL
- ETHYLHEXYL METHOXYCRYLENE
- SILICON DIOXIDE
- AVOBENZONE
- CETEARETH-12
- CETYL PALMITATE
- GLYCERYL MONOSTEARATE
- SORBITAN OLIVATE
- EDETATE SODIUM
- PEG-80 SORBITAN PALMITATE
- CYCLOMETHICONE 4
- POLYOXYL 20 CETOSTEARYL ETHER
- NIACINAMIDE
- WATER
- CYCLOMETHICONE 5
- CETYL ALCOHOL
- ETHYLHEXYLGLYCERIN
- ALUMINUM OXIDE
- ALKYL (C12-15) BENZOATE
- KOJIC ACID
- PHENOXYETHANOL
- TROLAMINE
- GLUCONOLACTONE
- TRANEXAMIC ACID
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 82701-003 | 82701-003-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| eea0e7c8-73eb-6d70-e053-2a95a90a7674 | eea0e8a4-124c-744b-e053-2a95a90a711a | 2022-11-29 | Warnings | eea0e7c8-73eb-6d70-e053-2a95a90a7674 eea0e8a4-124c-744b-e053-2a95a90a711a |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.